We further found that the MPC1−/− cells significantly increased glycolysis and cell invasion, which is consistent with the negative correlation between MPC1 expression and patient survival rate [14, 50], indicating its tumor genetic role in prostate cancer. This evidence concerns the gene MPC1 and prostate carcinoma.